Deals of the day-Mergers and acquisitions

(Adds Nestle, AstraZeneca, Omnipol, Exxon Mobil and updates Unilever, Grubhub, Viagogo)

June 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:

** Nestle is exploring a potential sale of part of its North American water business, including the Pure Life brand, it said, as the food giant shifts focus to better performing brands.

** AstraZeneca Plc picked Emergent BioSolutions Inc to help produce the 300 million doses of the British drugmaker’s potential COVID-19 vaccine pledged to the United States.

** Czech defence and security group Omnipol said it had acquired domestic aircraft maker Aero Vodochody Aerospace in a joint venture with Hungarian businessman and former chief security adviser Andras Tombor.

** Exxon Mobil is preparing to restart the sale of its British North Sea assets after weaker oil prices and the coronavirus outbreak led to months of delay, industry and banking sources said.

** Unilever proposed to ditch its dual Anglo-Dutch legal structure and create a single company in Britain to give it more flexibility for mergers and acquisitions as the coronavirus pandemic overwhelms businesses worldwide.

** Just Eat Takeaway said its proposed $6 billion takeover of Grubhub to create a trans-Atlantic giant would give it the upper hand in the online food delivery market, where competitors are scrambling for share. ** Ticket reseller Viagogo has a week’s time to submit proposals addressing competition concerns over its $4.05 billion deal for the ticketing unit of U.S. e-commerce company eBay Inc , UK’s competition watchdog said.

** Royal Dutch Shell has launched the sale of its stakes in two oilfields and two pipelines in Norway, according to a sales document seen by Reuters.

** Shareholders owning more than 90% of Spanish exchange BME have accepted a 2.8 billon euros takeover offer from Swiss rival SIX, Spain’s stock market supervisor CNMV said.

** Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea’s Celltrion Inc for $278 million, it said.

** Bain Capital’s tender offer “substantially” undervalued Japanese nursing home operator Nichiigakkan Co and appeared to take “advantage of COVID-19 related weakness in the share price”, investment fund LIM Advisors said in a letter to management.

** Japan’s Mitsubishi Electric Corp said it would buy part of a plant in western Japan from Sharp Corp to meet growing demand for power management chips used in electric vehicles (EVs).

** Intesa Sanpaolo is confident it can overcome objections raised so far by Italy’s antitrust authority to its proposed takeover bid for rival UBI Banca, a top executive at the Italian lender was quoted as saying.

** Australia’s Beston Global Food Company said it was selling its dairy farms to Aurora Dairies for A$40.4 million, in a deal which may need regulatory approval due to the new stringent rules for foreign investment.

** Fiat Chrysler and Peugeot maker PSA face a lengthy EU antitrust investigation after declining to offer concessions to allay EU antitrust concerns about their planned $50 billion merger, people familiar with the matter said on Wednesday. (Compiled by C Nivedita and Ayanti Bera)